Browsing: Homepage Slider
At the Clinical Trials on Alzheimer’s Disease Congress this week, Biogen (MA, USA) has provided a detailed report on the latest aducanumab results, including why there was such a difference in the results between ENGAGE and EMERGE.
A recent set of studies reports how blood–brain barrier leakage may affect inflammation in the brain, potentially leading to acceleration of neurological aging in mice.
Artificial neurons have been developed in a first-of-its-kind achievement that closely resemble biological neurons, mimicking their responses to a range of stimulations.
Researchers have discovered a correlation between reaction time and white matter microstructure damage in patients with concussion, suggesting an alteration in signaling patterns as a result of mild traumatic brain injury.
At SfN Neuroscience 2019, we had the brilliant opportunity of interviewing Hemraj Dodiya about sex-specific effects of microbiome perturbations in an Alzheimer’s mouse model.
A preclinical study in mice has revealed that a specific miRNA could target and modulate the gut microbiome with precision, holding potential as a new treatment option for multiple sclerosis.
At SfN Neuroscience 2019, we had the pleasure of speaking with Suzanne Rivera to discover more about the round-table discussion on the ethical and social issues raised by neural–digital interfaces, including the prospect of human enhancement.
In this World Mental Health Day editorial, Dani Beck provides us with an overview of what the day entails and what general knowledge people should be aware of, as well as a focus on mental health issues in the realm of academia.